Physician profile
Brandon Nance
NPI 1134625148
$5,994.85
in general payments reported to CMS, 2019-2025
33 companies · $4,804 in 2025
The $4,804 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.77 · 2022: $264 · 2023: $502 · 2024: $400 · 2025: $4,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,595 · Food and Beverage: $2,050 · Travel and Lodging: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,594.62 |
| Food and Beverage | $2,050.39 |
| Travel and Lodging | $891.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,482.19 | 2024-2025 | |
| Insmed, INC. | $310.35 | 2024-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $245.95 | 2025 | Tyvaso |
| Regeneron Healthcare Solutions, INC. | $205.11 | 2022-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $188.20 | 2022-2025 | Zerbaxa, Recarbrio, Dificid |
| La Jolla Pharmaceutical Company | $113.61 | 2024-2025 | Giapreza |
| Viatris Specialty LLC | $111.05 | 2025 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $103.62 | 2019-2025 | Fasenra, Andexxa, Farxiga |
| Actelion Pharmaceuticals US, INC. | $102.73 | 2022-2023 | Opsumit, Uptravi |
| Pfizer INC. | $102.60 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.40 | 2025 | |
| Verona Pharma, INC. | $76.74 | 2025 | Ohtuvayre |
| Grifols USA, LLC | $75.12 | 2022-2025 | Prolastin-C Liquid |
| Abiomed | $72.53 | 2024-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.28 | 2025 | Jascayd, Ofev |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $64.57 | 2022-2025 | |
| Livanova USA, INC. | $36.08 | 2022-2023 | Lifesparc |
| Alnylam Pharmaceuticals INC. | $33.46 | 2025 | Onpattro |
| Electromed, INC. | $31.74 | 2023-2024 | Smartvest |
| Mylan Specialty L.P. | $31.27 | 2023 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $31.00 | 2025 | Eliquis |
| Abbvie INC. | $30.98 | 2022-2023 | |
| Vifor Pharma, INC. | $25.10 | 2024 | Zemaira |
| Daiichi Sankyo INC. | $23.71 | 2025 | Injectafer |
| Pinnacle Biologics, INC | $22.94 | 2025 | Photofrin |
| Atricure, INC. | $21.89 | 2022 | |
| Ambu INC. | $21.73 | 2022 | |
| Baxter Healthcare | $21.46 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Jazz Pharmaceuticals INC. | $19.01 | 2025 | |
| Zoll Circulation INC | $18.91 | 2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Abbott Laboratories | $17.98 | 2022 | |
| Csl Behring | $16.51 | 2025 | Kcentra |
| Glaxosmithkline, LLC. | $14.50 | 2023 | Trelegy Ellipta, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Nance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.